| Literature DB >> 7367868 |
W Chavin, E J Jelonek, A H Reed, L R Binder.
Abstract
In BALB/c female mice with melanoma transplants, the incidence of "takes" is decreased and survival is increased by hydroquinone, a melanocytolytic agent. The mechanism of drug action is suggested by via DNA. The significant and high degree of positive response to hydroquinone treatment in vivo is encouraging for the clinical management of melanoma with melanocytolytic agents.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7367868 DOI： 10.1126/science.7367868
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728